Skip to main content
OpenTrials
Completed

NCT Number: NCT02118181

Assessment of Physical Performance With A Supplementation Containing HMB in a Sample of Old Women in Good Health

The purpose of this study is to determine whether a supplementation containing β-Hydroxy-β-methylbutyrate is effective in the treatment of age-related muscle loss in a group of older women compared to a non interventional group

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age Related Muscle Loss

Age range

65 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

University of Padova

Padua, 35128, Italy

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • People over 65 years, not residents in nursing home, in good health
  • Mini Mental State Examination (corrected for scholarity) more than 23

Exclusion criteria

  • Previous oral supplementation with proteins or minerals
  • important co-mordidities, such renal or hepatic failure

Treatment and study plan

HMB

Dietary Supplement

Primary outcomes

  1. Change in Short Physical Performance Battery

    Time frame: Baseline and after 2 months

Sponsors and collaborators

Lead sponsor

University of Padova

Other

Registry information

Official study title

Role of Oral Supplementation of Proteins and β-hydroxy-β-methyl Butyrate (HMB) in a Sample of Older Women in Good Health

Acronym: HMB

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Apr 21, 2014
Registry last updated
Dec 3, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.